Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer Targeted Oncology
Finance, IT & News
Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer Targeted Oncology
Haemonetics says FDA clears vascular closure device Reuters
FDA Approves Ryzumvi Eye Drops for Presbyopia Medscape
The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that…
FDA approves first heart valve designed to grow with kids born with congenital heart disease WPXI